[
  {
    "ts": null,
    "headline": "DaVita HealthCare (DVA) Stock Slides as Market Rises: Facts to Know Before You Trade",
    "summary": "In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $128.14, denoting a -2.3% move from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=8790da7213ab4c475423d1d7afed3c63a3990e0ac4e8b2c83c8950970e0c929f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759788905,
      "headline": "DaVita HealthCare (DVA) Stock Slides as Market Rises: Facts to Know Before You Trade",
      "id": 136999817,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $128.14, denoting a -2.3% move from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=8790da7213ab4c475423d1d7afed3c63a3990e0ac4e8b2c83c8950970e0c929f"
    }
  },
  {
    "ts": null,
    "headline": "1 Healthcare Stock to Consider Right Now and 2 We Brush Off",
    "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 13.9% return has trailed the S&P 500 by 18.8 percentage points.",
    "url": "https://finnhub.io/api/news?id=1ab73e334e64e613291584e3a6e255efcb8918a40dc39776e27b9636609764de",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759725392,
      "headline": "1 Healthcare Stock to Consider Right Now and 2 We Brush Off",
      "id": 136989520,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 13.9% return has trailed the S&P 500 by 18.8 percentage points.",
      "url": "https://finnhub.io/api/news?id=1ab73e334e64e613291584e3a6e255efcb8918a40dc39776e27b9636609764de"
    }
  }
]